• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨源性激素在葡萄糖代谢、糖尿病肾病及心血管疾病中的作用

The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders.

作者信息

Takashi Yuichi, Kawanami Daiji

机构信息

Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

出版信息

Int J Mol Sci. 2022 Feb 21;23(4):2376. doi: 10.3390/ijms23042376.

DOI:10.3390/ijms23042376
PMID:35216490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8879859/
Abstract

Bone contributes to supporting the body, protecting the central nervous system and other organs, hematopoiesis, the regulation of mineral metabolism (mainly calcium and phosphate), and assists in respiration. Bone has many functions in the body. Recently, it was revealed that bone also works as an endocrine organ and secretes several systemic humoral factors, including fibroblast growth factor 23 (FGF23), osteocalcin (OC), sclerostin, and lipocalin 2. Bone can communicate with other organs via these hormones. In particular, it has been reported that these bone-derived hormones are involved in glucose metabolism and diabetic complications. Some functions of these bone-derived hormones can become useful biomarkers that predict the incidence of diabetes and the progression of diabetic complications. Furthermore, other functions are considered to be targets for the prevention or treatment of diabetes and its complications. As is well known, diabetes is now a worldwide health problem, and many efforts have been made to treat diabetes. Thus, further investigations of the endocrine system through bone-derived hormones may provide us with new perspectives on the prediction, prevention, and treatment of diabetes. In this review, we summarize the role of bone-derived hormones in glucose metabolism, diabetic kidney disease, and cardiovascular disorders.

摘要

骨骼有助于支撑身体、保护中枢神经系统和其他器官、进行造血、调节矿物质代谢(主要是钙和磷),并辅助呼吸。骨骼在身体中有多种功能。最近发现,骨骼还作为一种内分泌器官发挥作用,分泌多种全身性体液因子,包括成纤维细胞生长因子23(FGF23)、骨钙素(OC)、硬化蛋白和lipocalin 2。骨骼可通过这些激素与其他器官进行交流。特别是,据报道这些骨源性激素参与葡萄糖代谢和糖尿病并发症。这些骨源性激素的一些功能可成为预测糖尿病发病率和糖尿病并发症进展的有用生物标志物。此外,其他功能被认为是预防或治疗糖尿病及其并发症的靶点。众所周知,糖尿病现在是一个全球性的健康问题,人们已经为治疗糖尿病做出了很多努力。因此,通过骨源性激素对内分泌系统进行进一步研究可能会为我们提供关于糖尿病预测、预防和治疗的新视角。在这篇综述中,我们总结了骨源性激素在葡萄糖代谢、糖尿病肾病和心血管疾病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23f4/8879859/93ba3b17c06f/ijms-23-02376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23f4/8879859/93ba3b17c06f/ijms-23-02376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23f4/8879859/93ba3b17c06f/ijms-23-02376-g001.jpg

相似文献

1
The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders.骨源性激素在葡萄糖代谢、糖尿病肾病及心血管疾病中的作用
Int J Mol Sci. 2022 Feb 21;23(4):2376. doi: 10.3390/ijms23042376.
2
The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease.骨源性激素在糖尿病及其肾脏并发症中的新作用。
Front Endocrinol (Lausanne). 2022 Jul 11;13:938830. doi: 10.3389/fendo.2022.938830. eCollection 2022.
3
[Bone-derived hormones and their systemic regulation.].[骨源性激素及其全身调节。]
Clin Calcium. 2018;28(1):9-15.
4
Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology.骨源性激素在 2 型糖尿病和心血管病理生理学中的作用。
Mol Metab. 2020 Oct;40:101040. doi: 10.1016/j.molmet.2020.101040. Epub 2020 Jun 13.
5
The bone hormones and their potential effects on glucose and energy metabolism.骨激素及其对葡萄糖和能量代谢的潜在影响。
Endocr Regul. 2019 Oct 1;53(4):268-273. doi: 10.2478/enr-2019-0027.
6
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones.骨钙素和硬骨素:候选的骨源激素。
Front Endocrinol (Lausanne). 2021 Mar 10;12:584147. doi: 10.3389/fendo.2021.584147. eCollection 2021.
7
[Bone and metabolism].[骨骼与新陈代谢]
Ann Endocrinol (Paris). 2018 Sep;79 Suppl 1:S40-S47. doi: 10.1016/S0003-4266(18)31236-8.
8
Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans.载脂蛋白 L2:一种源自于骨的致厌食和促进β细胞的信号:从老鼠到人。
J Diabetes. 2024 Mar;16(3):e13504. doi: 10.1111/1753-0407.13504. Epub 2023 Nov 30.
9
[Updates on Lifestyle-Related Diseases and Bone Metabolism. Bidirectional relationship between lifestyle-related diseases and bone metabolism].[生活方式相关疾病与骨代谢的最新进展。生活方式相关疾病与骨代谢之间的双向关系]
Clin Calcium. 2014 Nov;24(11):1591-8.
10
[The regulation of various organs by osteoblasts].[成骨细胞对各器官的调节作用]
Clin Calcium. 2016 May;26(5):721-7.

引用本文的文献

1
Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs.骨源因子介导骨骼与骨骼外器官之间的相互作用。
Bone Res. 2025 Apr 30;13(1):49. doi: 10.1038/s41413-025-00424-1.
2
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.糖尿病肾病的发病机制、生物标志物及治疗方法:当前见解与未来展望
J Clin Med. 2025 Jan 23;14(3):727. doi: 10.3390/jcm14030727.
3
Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment.

本文引用的文献

1
Bone fragility in diabetes: novel concepts and clinical implications.糖尿病中的骨脆性:新概念与临床意义
Lancet Diabetes Endocrinol. 2022 Mar;10(3):207-220. doi: 10.1016/S2213-8587(21)00347-8. Epub 2022 Jan 31.
2
Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study.骨钙素与新发糖尿病及糖尿病肾病风险:一项 4.6 年的前瞻性队列研究。
Diabetes Care. 2022 Apr 1;45(4):830-836. doi: 10.2337/dc21-2113.
3
Lipocalin-2: Structure, function, distribution and role in metabolic disorders.
硬化素与心血管风险:评估罗莫佐单抗治疗骨质疏松症时的心血管安全性
Biomedicines. 2024 Dec 18;12(12):2880. doi: 10.3390/biomedicines12122880.
4
Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM.骨钙素和中国内脏脂肪指数与 T2DM 患者 ASCVD 和动脉僵硬度的风险相关。
Sci Rep. 2024 Nov 5;14(1):26756. doi: 10.1038/s41598-024-77620-2.
5
Healthy eating index and bone health markers in adults with metabolically healthy and unhealthy obese phenotypes.具有代谢健康和不健康肥胖表型的成年人的健康饮食指数与骨骼健康标志物
Hum Nutr Metab. 2023 Jun;32:200186. doi: 10.1016/j.hnm.2023.200186. Epub 2023 Feb 21.
6
Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality.代谢综合征、骨源性细胞因子以及最常见的与代谢综合征相关的、对骨质量产生负面影响的疾病之间的相互关系。
Diabetol Metab Syndr. 2024 Sep 6;16(1):217. doi: 10.1186/s13098-024-01440-7.
7
Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues.骨质疏松性髋部骨折结局的预测:27种免疫炎症代谢标志物的比较准确性及相关概念问题
J Clin Med. 2024 Jul 7;13(13):3969. doi: 10.3390/jcm13133969.
8
Nutritional therapy bridges the critical cut-off point for the closed-loop role of type 2 diabetes and bone homeostasis: A narrative review.营养治疗跨越了2型糖尿病与骨稳态闭环作用的关键临界点:一项叙述性综述。
Heliyon. 2024 Mar 22;10(7):e28229. doi: 10.1016/j.heliyon.2024.e28229. eCollection 2024 Apr 15.
9
Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases.目前对骨源因子骨钙素的认识:其在糖尿病、骨质疏松症、石骨症和炎性关节疾病的治疗和管理中的作用。
J Mol Med (Berl). 2024 Apr;102(4):435-452. doi: 10.1007/s00109-024-02418-8. Epub 2024 Feb 16.
10
Serum Osteocalcin, Sclerostin and Lipocalin-2 Levels in Adolescent Boys with Obesity over a 12-Week Sprint Interval Training.肥胖青少年男孩进行12周冲刺间歇训练期间的血清骨钙素、硬化蛋白和 lipocalin-2水平
Children (Basel). 2023 May 8;10(5):850. doi: 10.3390/children10050850.
脂联素 2:结构、功能、分布及在代谢紊乱中的作用。
Biomed Pharmacother. 2021 Oct;142:112002. doi: 10.1016/j.biopha.2021.112002. Epub 2021 Aug 27.
4
Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span.骨骼中的成纤维细胞生长因子受体1(FGFR1)信号传导对于成纤维细胞生长因子23(FGF23)调节血清磷酸盐水平和正常寿命是必需的。
Biochem Biophys Rep. 2021 Aug 17;27:101107. doi: 10.1016/j.bbrep.2021.101107. eCollection 2021 Sep.
5
Phosphate and fibroblast growth factor 23 in diabetes.磷酸盐和成纤维细胞生长因子 23 在糖尿病中的作用。
Clin Sci (Lond). 2021 Jul 30;135(14):1669-1687. doi: 10.1042/CS20201290.
6
The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update.1 型和 2 型糖尿病患者髋部和非脊柱骨折的风险:系统评价和荟萃分析更新。
Bone. 2020 Aug;137:115457. doi: 10.1016/j.bone.2020.115457. Epub 2020 May 29.
7
Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes.颈动脉内膜中层厚度增高诱导的高强度间歇训练可降低 2 型糖尿病患者血清 Dkk-1 和 Sclerostin 水平。
J Diabetes Complications. 2020 Jan;34(1):107469. doi: 10.1016/j.jdiacomp.2019.107469. Epub 2019 Nov 1.
8
Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.2型糖尿病患者的椎体骨折:不仅仅是骨骼并发症
Diabetes Care. 2020 Jan;43(1):137-144. doi: 10.2337/dc19-0925. Epub 2019 Oct 28.
9
The Potential Role of Undercarboxylated Osteocalcin Upregulation in Microvascular Insufficiency in a Rat Model of Diabetic Cardiomyopathy.羧化不全骨钙素上调在糖尿病性心肌病大鼠模型微血管功能不全中的潜在作用
J Cardiovasc Pharmacol Ther. 2020 Jan;25(1):86-97. doi: 10.1177/1074248419876632. Epub 2019 Sep 18.
10
Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function.成纤维细胞生长因子 23 与 2 型糖尿病且肾功能正常或轻度受损患者的死亡率。
Diabetes Care. 2019 Nov;42(11):2151-2153. doi: 10.2337/dc19-0528. Epub 2019 Sep 5.